<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02395393</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-P00017377</org_study_id>
    <nct_id>NCT02395393</nct_id>
  </id_info>
  <brief_title>Confocal Fluorescence Microscopy of the Human Airways in Diagnostics of Lung Transplantation</brief_title>
  <official_title>Confocal Fluorescence Microscopy of the Human Airways in Diagnostics of Lung Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Children’s Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bronchoscopy-guided tissue sampling is a central technique in many diseases including
      diagnosing and staging lung cancers, diagnosing interstitial lung diseases, and acute and/or
      chronic rejections following lung transplantation. Confocal fluorescence microscopy is a
      novel technique used for real-time microscopic imaging of proximal and distal airways,
      microvessels, and inflammatory cells. We hypothesize that confocal fluorescence microscopy
      images of airways and alveolar structures during standard bronchoscopy could help recognize
      and classify the presence or absence of acute or chronic rejection in lung transplant
      recipients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bronchoscopy-guided tissue sampling is a central technique in many diseases including
      diagnosing and staging lung cancers, diagnosing interstitial lung diseases, and acute and/or
      chronic rejections following lung transplantation. Confocal fluorescence microscopy is a
      novel technique used for in vivo microscopic imaging of proximal and distal airways including
      bronchial and alveolar walls, microvessels, and inflammatory cells. We hypothesize that
      confocal fluorescence microscopy images of bronchiolar and alveolar structures during
      standard bronchoscopy could help recognize and classify the presence or absence of acute or
      chronic rejection in lung transplant recipients.

      The objectives and outcomes of this study are:

        1. To assess the safety of confocal microscopy imaging in pediatric patients

        2. To create diagnostic criteria for fibered confocal fluorescence microscopy image
           interpretation of acute and chronic rejections following lung transplantation

        3. To determine the sensitivity and specificity of confocal imaging in these patient groups
           compared to the transbronchial biopsies

        4. Correlate confocal images to FEV1 results

        5. Correlate with CXRs and/or CT images
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and specificity of confocal imaging in these patient groups compared to the transbronchial biopsies</measure>
    <time_frame>One year</time_frame>
    <description>Correlate confocal images to histolopathologic findings of acute rejection, chronic rejection, and no evidence of rejection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with adverse events</measure>
    <time_frame>One year</time_frame>
    <description>Monitor for serious adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of confocal images with FEV1 results</measure>
    <time_frame>One year</time_frame>
    <description>Measure the degree of fibrosis/collagen by confocal imaging and compare to FEV1 values</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Disorder Related to Lung Transplantation</condition>
  <arm_group>
    <arm_group_label>Lung transplant recipients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In patients scheduled for bronchoscopy as part of regular clinical care/diagnostic workup, the investigators will offer the patient concurrent confocal microscopy imaging to be performed during the bronchoscopic procedure. A 1.4mm or 1.9mm diameter Alveoflex Confocal MiniprobeTM (MaunaKea Technologies, France) will be deployed down the working channel of the standard bronchoscope and advanced distally into the alveoli.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alveoflex Confocal MiniprobeTM</intervention_name>
    <description>-Alveolar imaging</description>
    <arm_group_label>Lung transplant recipients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  to be older than six years of age

          -  to be undergoing surveillance or clinically indicated bronchoscopies with
             transbronchial biopsy as part of their routine care

          -  to be willing and able to comply with study procedures and provide written informed
             consent/assent to participate in the study

        Exclusion Criteria:

          -  to be unwilling to consent

          -  to be unable to safely tolerate a bronchoscopic procedure

          -  to have any contraindications to short-acting anesthetic agents

          -  to have any contraindications to transbronchial biopsies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>22 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gary Visner, DO</last_name>
    <role>Study Director</role>
    <affiliation>Boston Children’s Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Levent Midyat, MD</last_name>
    <phone>617-355-1900</phone>
    <email>levent.midyat@childrens.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kenan Haver, MD</last_name>
    <phone>617-355-1900</phone>
    <email>kenan.haver@childrens.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenan Haver</last_name>
    </contact>
    <investigator>
      <last_name>Katie Krone, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Izbicki G, Shitrit D, Yarmolovsky A, Bendayan D, Miller G, Fink G, Mazar A, Kramer MR. Is routine chest radiography after transbronchial biopsy necessary?: A prospective study of 350 cases. Chest. 2006 Jun;129(6):1561-4.</citation>
    <PMID>16778275</PMID>
  </reference>
  <reference>
    <citation>Hanson RR, Zavala DC, Rhodes ML, Keim LW, Smith JD. Transbronchial biopsy via flexible fiberoptic bronchoscope; results in 164 patients. Am Rev Respir Dis. 1976 Jul;114(1):67-72.</citation>
    <PMID>937843</PMID>
  </reference>
  <reference>
    <citation>Thiberville L, Salaün M, Lachkar S, Dominique S, Moreno-Swirc S, Vever-Bizet C, Bourg-Heckly G. Human in vivo fluorescence microimaging of the alveolar ducts and sacs during bronchoscopy. Eur Respir J. 2009 May;33(5):974-85. doi: 10.1183/09031936.00083708. Epub 2009 Feb 12.</citation>
    <PMID>19213792</PMID>
  </reference>
  <reference>
    <citation>Yserbyt J, Dooms C, Decramer M, Verleden GM. Probe-based confocal laser endomicroscopy of the respiratory tract: a data consistency analysis. Respir Med. 2013 Aug;107(8):1234-40. doi: 10.1016/j.rmed.2013.04.018. Epub 2013 May 23.</citation>
    <PMID>23706778</PMID>
  </reference>
  <reference>
    <citation>Thiberville L, Salaün M, Lachkar S, Dominique S, Moreno-Swirc S, Vever-Bizet C, Bourg-Heckly G. Confocal fluorescence endomicroscopy of the human airways. Proc Am Thorac Soc. 2009 Aug 15;6(5):444-9. doi: 10.1513/pats.200902-009AW. Review.</citation>
    <PMID>19687217</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2015</study_first_submitted>
  <study_first_submitted_qc>March 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2015</study_first_posted>
  <last_update_submitted>November 10, 2017</last_update_submitted>
  <last_update_submitted_qc>November 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children’s Hospital</investigator_affiliation>
    <investigator_full_name>Levent Midyat</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Acute rejection</keyword>
  <keyword>Chronic rejection</keyword>
  <keyword>Confocal microscopy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

